• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up1.22% Nasdaq Up2.00%

    QLT Inc. (QLTI)

    1.42 Up 0.02(1.43%) 4:00PM EDT
    ProfileGet Profile for:
    QLT Inc.
    887 Great Northern Way
    Suite 250
    Vancouver, BC V5T 4T5
    Canada - Map
    Phone: 604-707-7000
    Fax: 604-707-7001
    Website: http://www.qltinc.com

    Index Membership:N/A
    Full Time Employees:23

    Business Summary 

    QLT Inc., a biotechnology company, engages in the development and commercialization of ocular products that address the unmet medical needs of patients and clinicians worldwide. The company focuses on the development of QLT091001, a synthetic retinoid compound, which has been completed Phase Ib retreatment clinical trials for the treatment of leber congenital amaurosis and retinitis pigmentosa; Phase Ib clinical trials for the treatment of Retinitis Pigmentosa with autosomal dominant mutation in RPE65; and Phase IIa clinical trials for the treatment of impaired dark adaptation. QLT Inc. was founded in 1981 and is headquartered in Vancouver, Canada.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on QLT Inc.

    Key Executives 
    Dr. Geoffrey F. Cox Ph.D., BSc, 73
    Interim Chief Exec. Officer and Director
    Mr. William Glen Ibbott , 53
    Chief Financial Officer and Sr. VP of Fin.
    Dr. Lana Elizabeth Elizabeth Janes ,
    Chief Patent Officer and Sr. VP of Intellectual Property & Technology Devel.
    Ms. Dori C. Assaly ,
    Sr. VP of Legal and Corp. Sec.
    Amounts are as of Dec 31, 2015 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders